Efficacy of Dosimetric Versus Empiric Prescribed Activity of (131)I for Therapy of Differentiated Thyroid Cancer

BACKGROUND: The optimal management of high-risk patients with differentiated thyroid cancer (DTC) consists of thyroidectomy followed by radioiodine ((131)I) therapy. The prescribed activity of (131)I can be determined using two approaches: 1) empiric prescribed activity of (131)I (E-Rx); and 2) dosi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Endocrinol Metab
Päätekijät: Klubo-Gwiezdzinska, Joanna, Van Nostrand, Douglas, Atkins, Frank, Burman, Kenneth, Jonklaas, Jacqueline, Mete, Mihriye, Wartofsky, Leonard
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2011
Aiheet:
Endocrine Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7372577/
https://ncbi.nlm.nih.gov/pubmed/21849530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2011-0494
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia